Recent news flow and positive contract momentum is sufficient to provide investors with high visibility over a 45% growth rate. This growth rate will produce a record revenue base this year but the advent of supplemental market opportunities in new product areas means the demand curve facing Kromek is now at its steepest. Buy.
Companies: Kromek Group Plc
Albeit not wanting to tempt fate, 19th July 2021 will hopefully ‘go down’ in UK history as the day Covid switched from being a pandemic to an endemic disease. A watershed moment for the country, especially those 5.3m (& climbing) NHS patients sitting on waiting lists and holiday makers desperate to travel abroad after the removal of quarantine restrictions for ‘amber listed’ destinations.
Once the world is fully vaccinated, many investors incorrectly assume there will be no need for covid testing. Wrong. More contagious & deadlier variants are sure to appear, together with perhaps totally new infectious diseases that might even trigger another pandemic. Equally, the danger posed by deliberate (re rogue states, organised crime &/or terrorism) &/or even accidental (say a lab) biological release of harmful pathogens into the environmental isn’t going away anytime soon. The US govern
Kromek has been awarded a $6m contract extension from DARPA for the Phase II development of a biological threat detection system. The 28 month milestone based contract will account for a material amount of our forecast incremental revenue growth in 2022E. We believe the commercial value of the system once rolled out could provide a revenue opportunity materially in excess of the development value awarded to date.
After a quiet 1 st half (p/e Oct’21) due to the pandemic, Kromek is now enjoying a powerful rebound for its next generation, radiation detectors from existing & new medical (eg BMD, SPECT), nuclear (D3S) & security screening (Airport baggage/bottles) customers. Saying today that FY’21 results would be “in line with expectations”, with the Board equally being “excited” about the near-term prospects for its ground-breaking, biological threat detector. These mobile or static devices continuously te
An in-line update for FY21E means that losses have been contained by management's action on the cost base. Losses are not materially higher than in FY20A and sequential growth shows that revenues are recovering rapidly. With an identifiable pipeline of commercial opportunities, we see capacity for upside risk to financial forecasts to emerge this year.
Parsley Box, the direct to consumer provider of ready meals to the 60+ demographic, recently announced its AIM IPO plans. Parsley Box provides ready meals, which are not required to be stored in a fridge or freezer, have a shelf life of up to six months and are cooked in minutes. The company reported revenue of £24.4m for the financial year ended 31 December 2020 (unaudited). Deal details TBC and admission is expected to occur late March/ early April 2021. Caerus Mineral Resources, a London base
Companies: IES CTH IDEA PXEN LVCG NCCL DCTA KMK TRB
Despite the pandemic, smart investors continue to back world beating technology. So it is with Kromek, who yesterday confirmed that it had raised £13m gross at 15p/share from existing and new shareholders. The proceeds being earmarked to further develop the new ground-breaking biothreat/Covid airborne detector (see below), alongside optimising its CZT medical/nuclear imaging & D3S ‘dirty bomb’ commercialisation strategy. Whilst equally bolstering the balance sheet.
Kromek has raised £10m gross in a secondary placing to accelerate growth in new product areas and help strengthen the balance sheet. Our reinstated forecasts project a bounce back in revenues on identifiable revenue sources. We see several potential commercial opportunities which could provide material upside risk to our forecasts.
Research Tree provides access to ongoing research coverage, media content and regulatory news on Kromek Group Plc. We currently have 84 research reports from 6 professional analysts.
Upon publication of VRE’s interim results, we use this note to re-visit the investment case for VRE, together with a re-initiation of forecasts. Confirming the positive newsflow on client gains and sales growth over the H1 period, VRE posted an 83% increase in turnover to €1.25, with ENGAGE revenues 50% up on the total achieved in 2020. Our forecasts show a three-year turnover compound average growth rate (CAGR) of 91% to €9.8m in 2023E, in line with the objective to reach €10m of ENGAGE revenue
Companies: VR Education Holdings PLC
Companies: 1Spatial Plc
Companies: Bango plc
The Panoply has released a very strong trading update for the 5m to August which states trading is 'significantly ahead of expectations' and we raise our revenue forecasts by +7%. In the 5m period, the group secured c£50m of new contracts, nearly triple the £18m won in the same period last year and including a c£10m/5yr contract in the utilities sector. The Panoply is raising LFL revenue growth guidance from 10-15% to 15-20%, which feeds through to FY revenues of over £77m, compared with our pre
Companies: Panoply Holdings Plc
Exactly one year ago, the FTSE 100 closed at 5,862, having fallen 100 points on the day, the lowest point since mid-May 2020, due in part, to the strength of sterling vs US$ at $1.34. One year on, the FTSE 100 has risen to 7,119, a rise of 21%, it remains 7% below the peak in January 2020. From an international viewpoint, US and European markets continue to trade at record highs. The US Federal Reserve is close to withdrawing some of its economic support this year as inflation picks up and the e
Companies: AMYT BAG BVC BRSD CLG CML FBD GDWN INV MACF MNZS MIO NRR NSF NBI MATD PREM QFI RUA SCS STVG SUR SNX UPGS VAST VLS
Companies: Luceco PLC
Blackbird has delivered a strong set of first half results, hot on the heels of a landmark deal post period, its first ‘Powered by Blackbird’ licencing contract. H121 revenue grew by 21% to a record £867k, despite the adverse dollar impact. The gross margin was maintained at 90.4% and cash burn only marginally increased (by £97k), despite investment in sales and R&D, leaving net cash at £5.7m. Management reiterated they are well funded to break even. Numerous new partnership deals have been anno
Companies: Blackbird PLC
Blackbird plc* (BIRD.L, 38.0p/£128.1m) First OEM licensing deal (07.09.21) | CAP-XX Ltd* (CPX.L, 6.15p/£31.3m) Contract win: Selected for Spire's Health Tag (07.09.21) | Newmark Security plc* (NWT.L, 21.75p/£76.5m) Finals: Resilient performance; positive outlook (10.09.21)
Companies: BIRD CPX NWT
This is a positive 1H21 performance, seeing growth in all regions and customer segments, as well as a significant strengthening of the financial position; on track to meet profit expectations for FY21, and ahead on revenue forecasts. Dividends recommenced with the FY20 finals and now an Interim dividend of 0.2p has been declared (1H20: Nil). The financial strength also will allow Eleco to make substantial investment in its long-term growth in FY23 and FY24. Management is flagging investment in a
Companies: Eleco Plc
A positive trading update from Audioboom Group plc, one of the leading independent podcasting companies, results in the fourth significant upgrade to forecasts this year as the company continues to outpace growth of the global podcasting industry. This performance has been driven by continued growth in the Audioboom’s content-focused expansion plan with growth in premium advertising inventory, increased demand and strong pricing, and increased back catalogue inventory created by Audioboom’s prop
Companies: Audioboom Group PLC
MAST Energy Developments (MED) is to IPO on the Standard List on 14th April 2021 under the ticker MAST. The company has raised £5m giving a market capitalisation on listing of c. £23m. MED is currently a 100% subsidiary company of AIM quoted, Kibo Energy*. MED was established to acquire and develop a portfolio of flexible power plants in the UK and become a multi-asset operator in the rapidly growing Reserve Power market. PensionBee has confirmed its intention to float on the High Growth Se
Companies: SYM CGNR EKF KBT GGP VLS TMO ECK B90 MDZ
EMIS reported H121 results ahead of board expectations and is on track to meet the company’s FY21 expectations. After a period of investment to develop the EMIS-X platform, and at least a year of diverting resource to support customers’ COVID-19 efforts, EMIS is now in a position to execute its growth strategy. Our revenue and adjusted operating profit forecasts are unchanged, with revenue growth accelerating to the lower end of the targeted medium-term 5–9% range from FY22.
Companies: EMIS Group plc
Gaming Realms is a creator and licensor of innovative games for mobile, operating in the UK, US, Italy and Canada. Flagship brand Slingo® is a popular and unique game genre combining elements of slots, bingo and table gameplay. These games are licensed by some of the world’s biggest online gaming operators, including DraftKings, Sky Betting & Gaming and GVC, and distributed directly to operators or via global partners such as Scientific Games using the company's proprietary Remote Game Server pl
Companies: Gaming Realms PLC
Solid results, strong pipeline, rising resilience and high-value acquisition: Revenue was $18.6m, in line with expectations. H1 revenue represents 38% of our full year forecast, indicating an H2-weighted year as previously flagged. We expect tinyBuild to release seven new games in H2 compared to three in H1. Moreover, tinyBuild plans higher-profile releases in H2 (Potion Craft and Despot’s Game), which are already generating strong KPIs. EBITDA was $7.9m, slightly ahead of management’s expecta
Companies: tinyBuild Inc.
This latest UK airport contract is Journeo's third, and follows on from the deployment of its systems at Gatwick and Stansted. Looking more widely, investment made over the last few years in the group's technology base to deliver a cloud based modular hardware agnostic SaaS platform has positioned Journeo well in the wider market. With the market opportunity set to expand significantly over the next few years, we believe that Journeo is positioned extremely well to meet this demand through its
Companies: Journeo plc
